Cell injection aims to slow vision loss in rare eye disease
Disease control
Ongoing
This study tests the safety of a single injection of jCell (retinal progenitor cells) into the eye for people with retinitis pigmentosa, a genetic condition that causes vision loss. Sixty adults will receive either the active treatment or a sham injection, and researchers will mo…
Phase: PHASE2 • Sponsor: jCyte, Inc • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC